Citations
63
21.0 per year
Published
2022
Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial
The Lancet Regional Health - Americas•2022
Authors
G Reis, EASM Silva, DCM Silva, L Thabane, AC Ferreira, VEG Souza-Campos, AM Nogueira, APM de Almeida, EDS Callegari, ADF de Figueiredo-Neto, L Sprague, H Hendrickson, JI Forrest, P McKenzie, K Thorlund, EJ Mills
The Lancet
COVID-19
Abstract
Observational studies have postulated a therapeutic role of metformin in treating COVID-19. We conducted an adaptive platform clinical trial to determine whether metformin is efficacious in preventing COVID-19 related hospitalization or death.
Related Publications
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
The Lancet Global Health • 2022
The Lancet
COVID-19
Effect of early treatment with ivermectin among patients with Covid-19
New England Journal of Medicine • 2022
COVID-19
Ivermectin
Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis
The Lancet HIV • 2017
The Lancet
HIV/AIDS